Premier Biomedical Inc (BIEI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BIEI Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Premier Biomedical Inc manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2019)
(Sep 30 2019) (Jun 30 2019) (Mar 31 2019) (Dec 31 2018)
Assets
Cash & cash equivalent0.07
Cash & Short-term Investments0.00
Accounts receivable0.00
Inventories0.01
Other Current Assets0.01
Total Current Assets0.09
Equipment/Property/Plant Net0.01
Other Assets, Noncurrent0.00
Total Assets0.10
Liabilities
Accounts Payable, Current AC0.19
Interest Payable, Current IN0.06
Convertible Notes Payable, Current NO0.16
Other Liabilities, Current1.52
Total Current Liabilities1.93
Total Long-term Debt0.00
Deferred Tax Liabilities, Derivatives1.49
Total Liabilities1.93
Stockholders' Equity
Subscriptions Payable-
Common Stock Value0.00
Additional Paid In Capital Common Stock15.26
Retained Earnings / Accumulated Deficit-17.10
Other Equity0.00
Common Stockholder's Equity-1.83
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-1.83
Liabilities & Stockholder's Equity0.10
4 historic quarters locked

Sign in to unlock the full Premier Biomedical Inc balance sheet history.

About BIEI Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.